Sunday, November 10, 2019
- 9:00AM-11:00AM
-
Abstract Number: 564
ASDAS Is More Important Than BASDAI in Advanced Ankylosing Spondylitis
Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Axial Spondyloarthritis, Clinical Features- 9:00AM-11:00AM
-
Abstract Number: 198
Assessing Care Quality in Rheumatology Services
Epidemiology & Public Health Poster I: RA- 9:00AM-11:00AM
-
Abstract Number: 428
Assessing Meaningful Changes in Disease Activity as Clinical Trial Efficacy Measures for Cutaneous Lupus Erythematosus
Patient Outcomes, Preferences, & Attitudes Poster I: Patient Reported Outcomes- 9:00AM-11:00AM
-
Abstract Number: 655
Assessing Perceptions, Barriers, and Preferences to Exercise in Patients with Systemic Lupus Erythematosus
SLE – Clinical Poster I: Epidemiology & Pathogenesis- 9:00AM-11:00AM
-
Abstract Number: 630
Assessing the Humanistic and Economic Burden of Enthesitis Among Patients with Peripheral and Axial Spondyloarthritis: Results from a Multi-National Real World Survey Database
Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Axial Spondyloarthritis, Clinical Features- 9:00AM-11:00AM
-
Abstract Number: 333
Assessing the Relationship Between Gout and Return to Hemodialysis Among U.S. Renal Transplant Patients
Metabolic & Crystal Arthropathies Poster I: Clinical- 9:00AM-11:00AM
-
Abstract Number: 295
Assessing the Vascularization of Salivary Glands in Patients with Sjögren’s Syndrome – An OMERACT Ultrasound Group Reliability Exercise
Imaging Of Rheumatic Diseases Poster I- 9:00AM-11:00AM
-
Abstract Number: 496
Assessment of Anti-Cyclic Citrullinated Protein and Connective Tissue Disease Screening Questionnaire in Healthy Adults from the Oklahoma Immune Cohort
RA – Diagnosis, Manifestations, & Outcomes Poster I: Risk Factors, Predictors, & Prognosis- 9:00AM-11:00AM
-
Abstract Number: 528
Assessment of Bone and Cartilage Turnover Markers Following Treatment with Repository Corticotropin Injection in Patients with Persistently Active Rheumatoid Arthritis
RA – Treatments Poster I: Novel Treatments- 9:00AM-11:00AM
-
Abstract Number: 420
Assessment of Fatigue in Adults with Moderate to Severe Systemic Lupus Erythematosus (SLE): A Qualitative Study to Explore What Patients Feel Should Be Measured in Clinical Trials
Patient Outcomes, Preferences, & Attitudes Poster I: Patient Reported Outcomes- 9:00AM-11:00AM
-
Abstract Number: 743
Association Between Acute-phase Reactants, interleukin-6(IL6), Tumor Necrosis Factor-a(TNFa) and Disease Activity in Takayasu’s Arteritis During Follow-up with Repeated Evaluation of Vascular Imaging Manifestations
Vasculitis – Non-ANCA-Associated & Related Disorders Poster I: Takayasu's Arteritis & Polymyalgia Rheumatica- 9:00AM-11:00AM
-
Abstract Number: 670
Association Between Ambient Air Pollutant Exposures and Childhood-Onset Systemic Lupus Erythematosus: A 12-Year Population-Based Cohort Study in Taiwan
SLE – Clinical Poster I: Epidemiology & Pathogenesis- 9:00AM-11:00AM
-
Abstract Number: 643
Association Between Neutrophil to Lymphocyte, Monocyte to Lymphocyte, and Platelet to Lymphocyte Ratios and Lupus Disease Activity and Lupus Nephritis
SLE – Clinical Poster I: Epidemiology & Pathogenesis- 9:00AM-11:00AM
-
Abstract Number: 635
Association Between Radiographic Progression and Cardiovascular Risk in Spondyloarthritis: Data from CoSpaR REGISTRY